(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202112 | 202012 | % Var | 202112 | 202012 | % Var | 202103 | 202003 | % Var | |
| Sales | 15.91 | 14.98 | 6.21 | 53.92 | 45.22 | 19.24 | 61.59 | 76.03 | -18.99 |
| Other Income | 0.29 | 0.29 | 0.00 | 0.99 | 1.19 | -16.81 | 1.91 | 1.35 | 41.48 |
| PBIDT | 1.84 | 1.11 | 65.77 | 5.71 | 3.89 | 46.79 | 5.22 | 4.38 | 19.18 |
| Interest | 0.23 | 0.25 | -8.00 | 0.62 | 0.62 | 0.00 | 0.87 | 0.67 | 29.85 |
| PBDT | 1.61 | 0.86 | 87.21 | 5.09 | 3.27 | 55.66 | 4.35 | 3.71 | 17.25 |
| Depreciation | 0.51 | 0.49 | 4.08 | 1.51 | 1.41 | 7.09 | 1.91 | 1.95 | -2.05 |
| PBT | 1.10 | 0.37 | 197.30 | 3.58 | 1.86 | 92.47 | 2.44 | 1.76 | 38.64 |
| TAX | 0.22 | 0.08 | 175.00 | 0.87 | 0.38 | 128.95 | 0.38 | 0.46 | -17.39 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.40 | -0.24 | 66.67 |
| PAT | 0.88 | 0.29 | 203.45 | 2.71 | 1.48 | 83.11 | 2.06 | 1.30 | 58.46 |
| Equity | 45.71 | 45.71 | 0.00 | 45.71 | 45.71 | 0.00 | 35.44 | 35.44 | 0.00 |
| PBIDTM(%) | 11.57 | 7.41 | 56.07 | 10.59 | 8.60 | 23.10 | 8.48 | 5.76 | 47.12 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1823.85 |
| Dr. Reddys Lab | 1280.60 |
| Cipla | 1337.40 |
| Zydus Lifesciences | 916.90 |
| Lupin | 2361.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: